Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Stathmin 1, a Therapeutic Target in Esophageal Carcinoma?

  • Machado-Neto, Joao Agostinho (Hematology and Hemotherapy Center-University of Campinas/Hemocentro-Unicamp, Instituto Nacional de Ciencia e Tecnologia do Sangue)
  • Published : 2014.08.15
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Akhtar J, Wang Z, Jiang WP, et al (2014a). Stathmin overexpression identifies high risk for lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma patients. J Gastroenterol Hepatol, 29, 944-50. https://doi.org/10.1111/jgh.12498
  2. Akhtar J, Wang Z, Yu C, et al (2014b). STMN-1 is a potential marker of lymph node metastasis in distal esophageal adenocarcinomas and silencing its expression can reverse malignant phenotype of tumor cells. BMC Cancer, 14, 28. https://doi.org/10.1186/1471-2407-14-28
  3. Akhtar J, Wang Z, Yu C, et al (2014c). Effectiveness of local injection of lentivirus-delivered stathmin shRNA in human gastric cancer xenograft mouse. J Gastroenterol Hepatol, [Epub ahead of print].
  4. Belletti B, Baldassarre G (2011). Stathmin: a protein with many tasks. New biomarker and potential target in cancer. Expert Opin Ther Targets, 15, 1249-66. https://doi.org/10.1517/14728222.2011.620951
  5. Holmfeldt P, Brannstrom K, Stenmark S, et al (2006). Aneugenic activity of Op18/stathmin is potentiated by the somatic Q18-->e mutation in leukemic cells. Mol Biol Cell, 17, 2921-30. https://doi.org/10.1091/mbc.E06-02-0165
  6. Liu F, Sun YL, Xu Y, et al (2013). Expression and phosphorylation of stathmin correlate with cell migration in esophageal squamous cell carcinoma. Oncol Rep, 29, 419-24.
  7. Misek DE, Chang CL, Kuick R, et al (2002). Transforming properties of a Q18-->E mutation of the microtubule regulator Op18. Cancer Cell, 2, 217-28. https://doi.org/10.1016/S1535-6108(02)00124-1
  8. Phadke AP, Jay CM, Wang Z, et al (2011). In vivo safety and antitumor efficacy of bifunctional small hairpin RNAs specific for the human Stathmin 1 oncoprotein. DNA Cell Biol, 30, 715-26. https://doi.org/10.1089/dna.2011.1240
  9. Shi X, Wang D, Ding K, et al (2010). GDP366, a novel small molecule dual inhibitor of survivin and Op18, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cells. Cancer Biol Ther, 9, 640-50. https://doi.org/10.4161/cbt.9.8.11269
  10. Wang F, Wang LX, Li SL, et al (2011). Downregulation of stathmin is involved in malignant phenotype reversion and cell apoptosis in esophageal squamous cell carcinoma. J Surg Oncol, 103, 704-15. https://doi.org/10.1002/jso.21870
  11. Wang F, Xuan XY, Yang X, et al (2014). Stathmin is a marker of progression and poor prognosis in esophageal carcinoma. Asian Pac J Cancer Prev, 15, 3613-8. https://doi.org/10.7314/APJCP.2014.15.8.3613